Use of the GeneReader NGS System in a clinical pathology laboratory: A comparative study
U Koitzsch, C Heydt, H Attig, I Immerschitt… - Journal of clinical …, 2017 - jcp.bmj.com
Despite its successful use in academic research, next-generation sequencing (NGS) still
represents many challenges for routine clinical adoption due to its inherent complexity and …
represents many challenges for routine clinical adoption due to its inherent complexity and …
[HTML][HTML] On-chip analysis of respiratory viruses from nasopharyngeal samples
M Ritzi-Lehnert, R Himmelreich, H Attig… - Biomedical …, 2011 - Springer
Abstract Point-of-care (PoC) testing followed by personalized efficient therapy of infectious
diseases may result in a considerable reduction of associated health care costs. Lab-on-a …
diseases may result in a considerable reduction of associated health care costs. Lab-on-a …
[HTML][HTML] Non‐invasive molecular profiling of skin lesions using tape‐stripping
T Kränke, M Loibner, E Arzberger… - Skin Research and …, 2023 - ncbi.nlm.nih.gov
1. BACKGROUND The incidence of malignant melanoma (MM) is continuously rising with
nearly 300.000 cases worldwide in 2018, mostly due to improved early detection. 1, 2 …
nearly 300.000 cases worldwide in 2018, mostly due to improved early detection. 1, 2 …
[HTML][HTML] Delivering on the Promise of NGS for Clinical Diagnostics
H Attig, K Bailey, Y Kong - clpmag.com
In the realm of basic medical research, next-generation sequencing (NGS) has rapidly
become a well-established technology. Its application in the study of cancer genetics has …
become a well-established technology. Its application in the study of cancer genetics has …
New Lab-on-a-Chip System for Infectious Disease Analysis
M Ritzi-Lehnert, J Claussen… - International …, 2010 - asmedigitalcollection.asme.org
Early diagnosis followed by personalised efficient therapy of infectious diseases (eg
respiratory diseases, meningitis, sepsis) can lead to considerable reduction of costs in …
respiratory diseases, meningitis, sepsis) can lead to considerable reduction of costs in …
[PDF][PDF] Development of a device platform for predictive and prognostic point-of-care testing using the example of pathogen identification
We present a device platform for point-of-care testing of whole blood samples. It enables the
determination of the viral load of blood on a processor-controlled device platform. For the …
determination of the viral load of blood on a processor-controlled device platform. For the …
[CITATION][C] Unleash the Power of Liquid Biopsy: The GeneReader NGS System, now for circulating free DNA (cfDNA) at a 1% variant allele fraction
F Winterbottom, S Hughes, D Lueerssen, J Blood… - Application Note, QIAGEN, 2016
[CITATION][C] Association for Molecular Pathology 2017 Global Congress on Molecular Pathology Abstracts–Author Index
FST Abreu, STT Adams, SST Agnihotri, MID Agrawal…
[CITATION][C] Delivering on the Promise of NGS for Clinical Diagnostics Published on March 12, 2018
H Attig, K Bailey, Y Kong
[CITATION][C] Allen, Richard A. OTH10 Allen, Samantha F. H20, H22, H36, TT12 Almasri, Eyad ST26 Almradi, Amro H26 Aloise, Martin N. G17
DST Abbott, SOTH Abbs, MTT Abdalla, JST Achenbach…